相关实验视频
Updated: Jul 13, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
雷姆睡眠行为障碍:对PD治疗疗法的影响
Jeanne S Feuerstein1,2, Amy Amara3
1Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA. Jeanne.feuerstein@cuanschutz.edu.
Current neurology and neuroscience reports
|October 13, 2023
概括
快速眼动睡眠行为障碍 (RBD) 是帕金森病 (PD) 的一个关键早期症状. 研究正在探索RBD治疗方法及其在开发PD新疗法中的作用.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 快速眼动睡眠行为障碍 (RBD) 是一种表现为快速眼动睡眠 (REM) 的类型的睡眠障碍,其特征是没有和梦境的快速眼动睡眠.
- 特别值得注意的是,RBD是同核蛋白病变,特别是帕金森病 (PD) 的前发症特征.
研究的目的:
- 审查当前对RBD,相关疾病和治疗方法的理解.
- 探索RBD研究对开发帕金森病治疗方法的影响.
主要方法:
- 审查当前的基础科学和临床研究RBD.
- 对RBD病理生理学的动物模型的研究.
- 对RBD自然史和治疗疗效的临床研究的分析.
主要成果:
- RBD越来越多地被认为是PD的前性标志物.
- 目前正在进行的研究重点是RBD病理生理学,动物模型和临床治疗.
- RBD为开发神经保护性和症状性PD疗法提供了一条新的途径.
结论:
- RBD是帕金森病的关键早期指标.
- 对RBD进行进一步的基础科学和临床研究对于推进PD疗法至关重要.
- 研究RBD为开发PD创新治疗提供了独特的机会.
相关概念视频
01:24Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
01:15Parkinson's Disease: Overview
579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
01:15REM Sleep Behavior Disorder
213
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
213
01:28Drug Therapy
49
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
49
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
01:26Psychosis: Goals of Pharmacotherapy
146
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
146